Global Ophthalmology Therapeutics Market
According to the report " Ophthalmology Therapeutics Market ", published by Market Data Forecast , the global market is projected to reach USD 31.87 Billion by 2021 , at a CAGR of 7.4 % from 2016 to 2021 .
Ophthalmology is the branch of medicine associated with the treatment of eye defects and diseases . With the recent advancements in genetics and stem cell biology , the mechanisms of many ophthalmic diseases are being revealed progressively . The market is showcasing evident potential in the mentioned forecasting period . Global market for Ophthalmology Therapeutics is driven by the growing prevalence for vision impairment , which was estimated to be 147 million in 2010 , and is estimated to reach 191 million in the world in 2021
Technological advancement in the field of medicine are also playing a major role in the growth of the market . Increasing geriatric population around the globe along with rise in disposable income are some of the other factors driving the market for Ophthalmology Therapeutics Market . However , lack of awareness about the various diseases associated with ophthalmology is a major factor restraining the growth of the market . Stringent regulatory framework and unclear reimbursement policies are also acting as hurdles for market growth .
Global Market for Ophthalmology Therapeutics is segmented based on Indication , End User and region
1 . Based on Indication
� � � � � � �
Glaucoma Dry Eye Syndrome Diabetic Retinopathy Retinal Vein Occlusion Age-related Macular Degeneration Macular Edema Allergic Conjunctivitis
2 . Based on End User
� � � �
Hospitals Eye Clinics Diagnostic Centres Patients
3 . Based on Geography
� � � �
North America Europe Asia-Pacific Latin America
+ 1 888-702-9626 | www . marketdataforecast . com | contact @ marketdataforecast . com